NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
Apr 25 04:00PM ET
28.43
Dollar change
-0.08
Percentage change
-0.28
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y-8.69% Shs Outstand Perf Week7.36%
SponsorALPS ETF Type Tagsequity Return% 3Y-3.54% Total Holdings103 Perf Month-4.22%
Fund Family Bond Type Tagshealthcare Return% 5Y-4.31% AUM82.39M Perf Quarter-12.06%
IndexS-Network Medical Breakthroughs Index Average Maturity Tagsbiotechnology Return% 10Y NAV% Perf Half Y-27.72%
Index Weighting Commodity Type Tagssmall-mid-cap Return% SI NAV/sh Perf Year-11.81%
Active/Passive Quant Type Tagsmedical Flows% 1M-0.93% 52W Range22.33 - 42.73 Perf YTD-13.93%
Dividend TTM1.17 (4.13%) ESG Type Tagsclinical-trials Flows% 3M-7.08% 52W High-33.47% Beta0.77
Dividend Ex-DateDec 19, 2024 Dividend Type Sector/Theme Flows% YTD-7.94% 52W Low27.32% ATR (14)1.02
Expense0.50% Structure Type Region Flows% 1Y RSI (14)54.39 Volatility2.28% 3.96%
Option/ShortYes / Yes Growth/Value Dev/Emerg Flows% 3Y Rel Volume0.92 Prev Close28.51
Inverse/Leveraged Market Cap Currency Flows% 5Y Avg Volume14.82K Price28.43
SMA206.91% SMA50-2.83% SMA200-17.80% Trades Volume13,574 Change-0.28%
Apr-23-25 05:45AM
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
06:05AM Loading…
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Oct-31-24 05:32PM
Feb-29-24 07:00AM
Jun-30-22 08:51AM
Apr-04-22 07:30AM
Mar-24-22 08:42AM
Mar-22-22 07:00AM
Aug-20-20 04:58PM
Jun-23-20 11:10AM
04:00PM Loading…
Apr-14-20 04:00PM
Feb-21-20 11:42AM
Feb-10-20 01:40PM
Dec-26-19 02:30PM
Dec-24-19 12:15PM
Dec-23-19 12:00PM
Dec-20-19 02:00PM
Dec-12-19 08:00AM
Dec-10-19 04:16PM
10:10AM
Dec-02-19 02:40PM
Nov-27-19 11:05AM
10:15AM
Nov-21-19 12:15PM
Nov-01-19 11:10AM
12:25PM Loading…
Oct-31-19 12:25PM
Oct-30-19 10:43AM
Oct-23-19 04:24PM
10:10AM
Sep-09-19 04:55PM
Sep-03-19 05:46PM
Aug-05-19 12:00PM
Jun-24-19 04:23PM
Jun-18-19 09:55AM
Jun-17-19 03:22PM
May-15-19 01:00PM
May-06-19 06:05PM
Apr-11-19 03:33PM
Apr-10-19 03:21PM
Mar-06-19 05:05PM
Feb-28-19 01:00PM
Feb-27-19 03:00PM
Feb-26-19 11:15AM
Feb-25-19 01:59PM
Feb-14-19 01:53PM
Jan-23-19 09:16AM
Jan-22-19 10:15AM
Jan-14-19 01:00PM
Jan-07-19 01:56PM
Dec-27-18 02:30PM
Nov-20-18 02:03PM
Oct-23-18 09:18AM
Oct-10-18 03:30PM
Sep-28-18 07:37AM
Sep-06-18 11:00AM
Jul-12-18 03:23PM
Jul-03-18 04:42PM
Jul-02-18 03:23PM
Jun-28-18 12:25PM
May-31-18 04:36PM
May-21-18 02:20PM
10:40AM
May-11-18 04:18PM
Apr-16-18 08:00AM
Mar-27-18 12:42PM
Jan-11-18 10:57AM
Jan-10-18 12:18PM
Dec-28-17 02:27PM
Dec-22-17 04:16PM
Sep-12-17 03:08PM
Aug-29-17 12:44PM
Aug-28-17 02:37PM
Jul-06-17 06:07PM
Jun-19-17 05:18PM
Jun-01-17 01:12PM
May-18-17 10:19AM
May-08-17 05:42PM
Mar-21-17 12:19PM
Mar-01-17 04:14PM
08:59AM
Feb-23-17 11:45AM
Jan-12-17 12:00PM
10:08AM
Dec-08-16 03:00PM
Nov-14-16 01:54PM
Nov-10-16 09:55AM
Nov-01-16 12:46PM
11:12AM
Oct-27-16 12:19PM
Oct-21-16 09:54AM
Sep-21-16 11:23AM
Sep-14-16 02:19PM
Sep-12-16 02:47PM
Aug-19-16 12:14PM
Aug-01-16 08:00AM
ALPS Medical Breakthroughs ETF seeks investment results that correspond (before fees and expenses) generally to the performance of its underlying index, the S-Network Medical Breakthroughs Index. The fund employs a "passive management" - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials.